T-Select Mouse CD1d Tetramer-PE

1. Yoshiga Y et al. Activation of natural killer T cells by α-carba-GalCer (RCAI-56), a novel synthetic glycolipid ligand, suppresses murine collagen-induced arthritis. Clin Exp Immunol. 164, 236-247 (2011)(PMID:21391989)

1. Horikoshi M et al. Activation of Invariant NKT cells with glycolipid ligand α-galactosylceramide ameliorates glucose-6-phosphate isomerase peptide-induced arthritis. PLoS One 7, e51215 (2012)(PMID:23251456)

1. Sekiya T et al. Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis. Nat Immunol 14, 230–7 (2013)(PMID:23334790)

1. Nakamura T et al. The nanoparticulation by octaarginine-modified liposome improves α-galactosylceramide-mediated antitumor therapy via systemic administration. J Control Release 171, 216–24 (2013)(PMID:23860186)

1. Adachi K et al. Involvement of IL-18 in the expansion of unique hepatic T cells with unconventional cytokine profiles during Schistosoma mansoni infection. PLoS One 9, e96042 (2014)(PMID:24824897)

1. Shimamura M et al. Activation of invariant natural killer T cells stimulated with microbial α-mannosyl glycolipids. Sci Rep. 7, 9703 (2017)(PMID:28852174)

1. Uchida T et al. Repeated administration of alpha-galactosylceramide ameliorates experimental lupus nephritis in mice. Sci Rep. 8, 8225 (2018)(PMID:29844470)

1. Shimizu K et al. Eomes transcription factor is required for the development and differentiation of invariant NKT cells. Commun Biol. 2, 150 (2019) (PMID:31044175)

Flow Cytometry

1. Hojo MAet al. Identification of a genomic enhancer that enforces proper apoptosis induction in thymic negative selection. Nat Commun. 10, 2603 (2019)(PMID:31197149)
2. Komine-Aizawa S et al. Cow milk exosomes activate NK cells and γδT cells in human PBMCs in vitro. Immunol Med. 43, 161-170 (2020)(PMID:32649844)